Bob Sikorski, M.D., Ph.D.
Bob Sikorski is a seasoned biotechnology executive who has extensive experience in leading pre-IND, early stage, and late stage drug development programs. Most recently, Bob served as the Chief Medical Officer for Five Prime Therapeutics. Previously, he was Senior Director, Global Oncology Clinical Development for MedImmune/AstraZeneca. Bob holds an M.D. and Ph.D. from the Johns Hopkins University School of Medicine.